The US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor as adjuvant treatment for adults with hormone receptor (HR)-positive, ...

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

Kisqali is a prescription drug used with other medications to treat certain kinds of breast cancer. Kisqali can cause side effects that range from mild to serious, such as fatigue, hair loss, and ...

Python implementation of the package url spec. This project is sponsored by NLnet project https://nlnet.nl/project/vulnerabilitydatabase/, the Google Summer of Code ...

This type of tumor, referred in shorthand as HR+ and HER2-, accounts for roughly 70% of all breast cancer cases in the U.S. Kisqali specifically targets a protein called CDK4/6, as does Eli Lilly’s ...

This package contains a PackageServiceProvider that you can use in your packages to easily register config files, migrations, and more. Here's an example of how it can be used. We invest a lot of ...

Just a few weeks after Eli Lilly claimed a key FDA approval for its CDK4/6 inhibitor Verzenio in early-stage breast cancer, Novartis has responded with phase 3 data for Kisqali that will lead to ...

When a table is created, it contains no data. The first thing to do before a database can be of much use is to insert data. Data is inserted one row at a time. You can also insert more than one row in ...